Specialised clinical AI tools demand continuous testing, risk assessment, and careful workflow alignment before they can be safely scaled across a health system, according to Lily Liu, Divisional Director of Digital Health at Western Health in Australia. The gap between adopting general-purpose AI and deploying clinical applications remains wide because patient-facing tools carry far higher stakes for consistency and safety.
"Specialised clinical AI carries a far higher threshold for consistency and safety - making its implementation uniquely complex compared to everyday general-purpose AI tools," Liu said in a HIMSSCast episode. She argued that successful scaling depends on health systems accounting for specific clinical environments, operational workflows, and the multidisciplinary teams supporting the technology, rather than expecting out-of-the-box software to adapt on its own.
The ecosystem problem
Liu cautioned that AI cannot be treated as a standalone fix. Fragmented workflows and inaccessible data can severely restrict its impact. She described AI as one element within a broader digital health ecosystem, where clinical staff, IT teams, and executive leaders must all be involved in design and testing - even when the algorithms themselves operate as a "black box."
A HIMSS APAC report previously highlighted the adoption gap between everyday AI tools and specialised clinical applications. The findings align with Liu's on-the-ground experience at Western Health, where implementation requires more than technical readiness. It demands organisational alignment across multiple departments that may not typically collaborate on technology decisions.
Workforce engagement and vendor collaboration
Getting clinicians and support staff behind AI tools means involving them early. Liu stressed that workforce buy-in does not happen through mandates or training sessions alone. It requires participation in testing and design phases so that teams understand how the tool fits their actual daily routines.
Vendor relationships also shape outcomes. Liu pointed to the need for health services to work directly with AI vendors to confirm compatibility with existing systems. Without that collaboration, even well-designed clinical AI can stall during integration. For public health services operating with constrained resources, efficient implementation becomes a priority from day one.
Organisations exploring clinical AI can benefit from structured learning paths that address sector-specific needs. AI for Healthcare training resources help teams understand what safe scaling requires before a tool ever reaches a patient. Similarly, administrative functions like billing are seeing parallel AI adoption, with role-specific guidance available through AI for Medical Billers courses that address the operational side of digital health.
Why this matters for healthcare professionals
Clinical AI projects fail more often during scaling than during pilot phases. The difference between a successful rollout and a stalled one frequently comes down to whether the organisation treated AI as a technology project or as a clinical workflow change. Healthcare professionals who understand this distinction - and who push for involvement in testing and design - position their teams to catch problems before they reach patients. The threshold for consistency that Liu describes is not a technical benchmark. It is a clinical one, and it requires clinical judgment to meet it.
Your membership also unlocks:
